CN Patent

CN114072150A — 新方法

Assigned to Intra Cellular Therapies Inc · Expires 2022-02-18 · 4y expired

What this patent protects

本公开提供了治疗II型双相性精神障碍的方法，该方法包括向需要其的患者施用治疗有效量的任选为氘化形式的游离或可药用盐形式的卢美哌隆。

USPTO Abstract

本公开提供了治疗II型双相性精神障碍的方法，该方法包括向需要其的患者施用治疗有效量的任选为氘化形式的游离或可药用盐形式的卢美哌隆。

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: CN114072150A
Jurisdiction: CN
Classification: —
Expires: 2022-02-18
Drug substance claim: No
Drug product claim: No
Assignee: Intra Cellular Therapies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.